2019
DOI: 10.1093/ecco-jcc/jjy222.343
|View full text |Cite
|
Sign up to set email alerts
|

P219 Retrospective investigation of tacrolimus combined with an anti-TNFα antibody as remission induction therapy for refractory ulcerative colitis: efficacy, safety, and relapse rate

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles